Overview
ICUI market data
Price History
ICUI price chart
Valuation & Profitability
- P/E (TTM)
- 97.95 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.03 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.87 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $110.51 – $192.85 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $4.5B · P/B 1.66 · P/S 2.10.
Company News
Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $195Benzinga · Aug 7, 2026, 5:04 PM
ICU Medical shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates. Also, BTIG and Needham raised their respective price targets on the stockBenzinga · Aug 7, 2026, 3:41 PM
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 EarningsBenzinga · Aug 7, 2026, 10:43 AM
BTIG Maintains Buy on ICU Medical, Raises Price Target to $200Benzinga · Aug 7, 2026, 10:15 AM
Needham Maintains Buy on ICU Medical, Raises Price Target to $187Benzinga · Aug 7, 2026, 9:59 AM
ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 EstBenzinga · Aug 6, 2026, 8:10 PM
ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 EstBenzinga · Aug 6, 2026, 8:10 PM
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M EstimateBenzinga · Aug 6, 2026, 8:07 PM
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $182Benzinga · Jul 21, 2026, 12:29 PM
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · Jun 15, 2026, 1:20 PM